课题基金 / 基金详情

项目摘要

项目成果

YOANNIS IMBERT-FERNANDEZ的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):干眼病是由于泪液缺乏或泪液过度蒸发而导致眼表炎症和损伤。黏液蛋白是一种高度o糖基化的蛋白,具有润滑和保护眼表的作用。最近的研究表明,黏液蛋白MUC1具有抗炎特性,并可与雌激素受体α相互作用,从而调节基因转录。雄激素是维持眼表内环境平衡的关键。MUC1和雄激素受体(AR)之间的潜在相互作用可能提供额外的保护:我的长期目标是阐明干眼症发病机制中的分子机制。我的假设是MUC1和雄激素受体(AR)是共同作用保护眼表的关键因素。该假设将通过三个特定目标进行验证:目标1-确定人眼表上皮细胞系MUC1和AR之间的相互作用;目的2-阐明MUC1和AR在这些细胞中的抗炎作用;我们发现表达MUC1/A剪接变体的人比表达MUC1/B剪接变体的人更不容易患干眼症。我们将确定MUC1/A和MUC1/B剪接变体的信号转导能力是否不同。
英文摘要
DESCRIPTION (provided by applicant): Dry eye disease is due to tear deficiency or excessive tear evaporation and results in inflammation and damage to the ocular surface. Mucins are highly O-glycosylated proteins that lubricate and protect the ocular surface. Recent findings indicate that the mucin MUC1 has anti-inflammatory properties and also can interact with estrogen receptor-alpha thereby modulating gene transcription. Androgens are key to maintaining homeostasis of the ocular surface. A potential interaction between MUC1 and androgen receptor (AR) could confer additional protection: My long term goal is to elucidate the molecular mechanisms involved in the pathogenesis of dry eye. My hypothesis is that MUC1 and androgen receptor (AR) are key factors that can act together to protect the ocular surface. The hypothesis will be tested by three specific aims: Aim 1- Determine the interaction between MUC1 and AR in human ocular surface epithelial cell lines; Aim 2- Elucidate the anti-inflammatory role of MUC1 and AR in those cells; and Aim 3- We have found that persons expressing the MUC1/A splice variant rather than MUC1/B are less susceptible to dry eye. We will determine if MUC1/A and MUC1/B splice variants differ in their signal transduction capabilities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors
  • 批准号:
    10650304
  • 项目类别:
  • 资助金额:
    $34.97万
  • 财政年份:
    2020
  • 负责人:
    YOANNIS IMBERT-FERNANDEZ
  • 依托单位:
Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors
  • 批准号:
    10052862
  • 项目类别:
  • 资助金额:
    $35.69万
  • 财政年份:
    2020
  • 负责人:
    YOANNIS IMBERT-FERNANDEZ
  • 依托单位:
Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors
  • 批准号:
    10430005
  • 项目类别:
  • 资助金额:
    $35.69万
  • 财政年份:
    2020
  • 负责人:
    YOANNIS IMBERT-FERNANDEZ
  • 依托单位:
Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors
  • 批准号:
    10213670
  • 项目类别:
  • 资助金额:
    $35.69万
  • 财政年份:
    2020
  • 负责人:
    YOANNIS IMBERT-FERNANDEZ
  • 依托单位:
海外基金